StonvexLoading…
StonvexStonvexStonvexCore line items from DKL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $297.47M | $1.01B | $757.56M | $496.28M |
Operating Income | $40.01M | $181.84M | $145.40M | $100.03M |
Net Income | $32.35M | $176.46M | $129.17M | $83.61M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $2.91B | $2.78B | $2.75B | $2.75B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.91M | $10.89M | $6.91M | $1.44M |
Free Cash Flow OCF − CapEx | $121.85M | $-30.64M | $-43.23M | $-30.98M |
Shares Outstanding | Not available | Not available | Not available | Not available |